{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:06Z","timestamp":1791332526114,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.diabet.2007.04.005","type":"journal-article","created":{"date-parts":[[2007,11,5]],"date-time":"2007-11-05T12:19:27Z","timestamp":1194265167000},"page":"385-389","source":"Crossref","is-referenced-by-count":39,"title":["Efficacy of\u00a0pioglitazone in\u00a0familial partial lipodystrophy of\u00a0the\u00a0Dunnigan type: a\u00a0case report"],"prefix":"10.1016","volume":"33","author":[{"given":"F.","family":"Moreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Boullu-Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lucescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ruimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Guerci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pinget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Jeandidier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2007.04.005_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","article-title":"Genetic disorders of adipose tissue development, differentiation, and death","volume":"7","author":"Agarwal","year":"2006","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.diabet.2007.04.005_bib2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1042\/BST20051073","article-title":"Diseases of adipose tissue: genetic and acquired lipodystrophies","volume":"33","author":"Capeau","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.diabet.2007.04.005_bib3","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s00125-005-0038-x","article-title":"Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamina A\/C","volume":"48","author":"Wong","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2007.04.005_bib4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/01.ATV.0000136392.59656.8b","article-title":"Laminopathies and atherosclerosis","volume":"24","author":"Al Shali","year":"2004","journal-title":"Arterioscler Throm Vasc Biol"},{"key":"10.1016\/j.diabet.2007.04.005_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1046\/j.1464-5491.2002.00796.x","article-title":"Post mortem findings in familial partial lipodystrophy, Dunnigan variety","volume":"19","author":"Haque","year":"2002","journal-title":"Diabet. Med."},{"key":"10.1016\/j.diabet.2007.04.005_bib6","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.49.11.1958","article-title":"Lamin A\/C. Gene: sex determined expression of mutations in Dunnigan \u2013 type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy","volume":"49","author":"Vigouroux","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2007.04.005_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1399-0004.2006.00677.x","article-title":"The laminopathies: a clinical review","volume":"70","author":"Rankin","year":"2006","journal-title":"Clin. Genet."},{"key":"10.1016\/j.diabet.2007.04.005_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-133-4-200008150-00009","article-title":"Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes","volume":"133","author":"Arioglu","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.diabet.2007.04.005_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1464-5491.2003.01034.x","article-title":"Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene","volume":"20","author":"Owen","year":"2003","journal-title":"Diabet. Med."},{"key":"10.1016\/j.diabet.2007.04.005_bib10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1464-5491.2005.01757.x","article-title":"Long \u2013 term treatment experience in a subject with Dunnigan \u2013 type familial partial lipodystrophy: efficacy of rosiglitazone","volume":"22","author":"L\u00fcdtke","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.diabet.2007.04.005_bib11","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1210\/jc.2003-031658","article-title":"Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities","volume":"89","author":"Vantyghem","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.diabet.2007.04.005_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.med.57.022605.114424","article-title":"Genetic basis of lipodystrophies and management of metabolic complications","volume":"57","author":"Agarwal","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.diabet.2007.04.005_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3132\/dvdr.2006.005","article-title":"Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidemia after treatment conversion from rosiglitazone while continuing stable statin therapy","volume":"3","author":"Berhanu","year":"2006","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"Suppl.2","key":"10.1016\/j.diabet.2007.04.005_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1185\/030079906X112732","article-title":"Metformin and pioglitazone: effectively treating insulin resistance","volume":"22","author":"Staels","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.diabet.2007.04.005_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"O\u2019Rahilly PPAR\u03b3 and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.diabet.2007.04.005_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cll.2004.01.007","article-title":"Adipocytes biology and adipocytokines","volume":"24","author":"Haque","year":"2004","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.diabet.2007.04.005_bib17","unstructured":"Yang Y, Smith U. Adipose tissue distribution and risk of metabolic diseases: does TZD induced adipose redistribution provides a clue to the answer? Diabetologia ahead of print D01 10 1007\/300125 001."},{"key":"10.1016\/j.diabet.2007.04.005_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modelling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2007.04.005_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.20012","article-title":"A pilot study of pioglitazone treatment for non-alcoholic steatohepatitis","volume":"39","author":"Promrat","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.diabet.2007.04.005_bib20","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo controlled trial of pioglitazone in subjects with non-alcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabet.2007.04.005_bib21","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2005.00234.x","article-title":"Hepatic steatosis in Dunnigan-type familial partial lipodystrophy","volume":"100","author":"Ludtke","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.diabet.2007.04.005_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/hmg\/11.7.769","article-title":"A novel interaction between lamin A and SREBP1: Implications for partial lipodystrophy and other laminopathies","volume":"11","author":"Lloyd","year":"2002","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.diabet.2007.04.005_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/hmg\/ddi158","article-title":"Altered pre-lamin A processing is a common mechanism leading to lipodystrophy","volume":"14","author":"Capanni","year":"2005","journal-title":"Hum. Mol. Gen."}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363607001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363607001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T08:56:52Z","timestamp":1546505812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363607001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S1262363607001814"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2007.04.005","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}